feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Weight Loss Drugs Halve Asthma Attacks in Teens

Weight Loss Drugs Halve Asthma Attacks in Teens

2 Jan

•

Summary

  • New drugs for weight management reduced severe asthma attacks by half in teens.
  • GLP-1 medications mimic a hormone to control blood sugar and decrease appetite.
  • Weight loss is believed to reduce inflammation linked to worse asthma symptoms.

Severe asthma attacks in teenagers struggling with excess weight may be cut in half through the use of advanced weight-loss drugs. Research published on December 29, 2025, in JAMA Network Open revealed that teens prescribed GLP-1 medications experienced a significant reduction in asthma exacerbations.

These GLP-1 drugs work by mimicking the body's GLP-1 hormone, which aids in regulating insulin and blood sugar while also suppressing appetite and slowing digestion. During a 12-month study period, adolescents taking these medications had fewer asthma-related emergency room visits compared to their peers not on the drugs.

Experts suggest that the weight loss induced by these medications is key to improving asthma control, as obesity contributes to body inflammation that can worsen asthma symptoms. The drugs offer a potential dual benefit, addressing both weight management and reducing the risk of severe asthma episodes in this vulnerable population.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
trending

Fatal mountain lion attack reported

trending

BYD surpasses Tesla EV sales

trending

Google's AI drives stock rebound

trending

Mexico earthquake shakes southern region

trending

Jonathan Boley's father charged

trending

Musk defiant on Tesla CEO

trending

AI demand boosts NVDA stock

trending

USA Hockey Olympics roster unveiled

trending

Apple stock strong Q3 performance

Yes, a new study indicates that GLP-1 weight-loss drugs can reduce severe asthma attacks by half in overweight or obese teenagers.
GLP-1 drugs aid in weight management by mimicking a hormone that controls appetite and blood sugar, leading to reduced inflammation and fewer asthma exacerbations in teens.
Obesity can cause inflammation in the body, which is linked to more frequent and severe asthma attacks in teenagers.

Read more news on

Healthside-arrow

You may also like

Ozempic Effect: Restaurants Serve Mini-Meals

23 Dec, 2025 • 63 reads

article image

GLP-1 Drugs: Hope, Hurdles, and Health in America

18 Dec, 2025 • 55 reads

article image

Expert Warns: Mould Worsens Health Woes

15 Dec, 2025 • 55 reads

article image

Flu Vaccine Saved My Life: Lung Transplant Hope

13 Dec, 2025 • 89 reads

article image

Diwali pollution: New asthma risk for kids

26 Nov, 2025 • 162 reads

article image